Colorectal cancer as a complex disease: defining at-risk subjects in the general population – a preventive strategy

Over the last few decades it has become clear that highly penetrant disease genes are responsible for a minor proportion of colorectal cancer cases. Families with hereditary syndromes are today recognized and included in surveillance programs known to reduce morbidity and mortality in colorectal cancer. Colorectal cancer is preventable and screening strategies in whole populations are currently under debate. Colorectal cancer can be considered a complex disease, with a combination of predisposing genetic variants and environmental factors that contribute to the illness as a whole. The progress made in the genome project provides an opportunity to determine such genetic variants and environmental factors. This knowledge can be used to define a subpopulation at increased risk for colorectal cancer. It will be more feasible to design preventive strategies for this subgroup than for a whole population.

[1]  A. Lindblom,et al.  Definition of candidate low risk APC alleles in a Swedish population , 2004, International journal of cancer.

[2]  B. Nilsson,et al.  Individuals with an increased risk of colorectal cancer: perceived benefits and psychological aspects of surveillance by means of regular colonoscopies. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  W. Willett,et al.  Comparison of risk factors for colon and rectal cancer , 2004, International journal of cancer.

[4]  L. Lipton,et al.  Carcinogenesis in MYH-associated polyposis follows a distinct genetic pathway. , 2003, Cancer research.

[5]  R. Elston,et al.  A subset of familial colorectal neoplasia kindreds linked to chromosome 9q22.2-31.2 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[6]  M. Leshno,et al.  The I1307K adenomatous polyposis coli gene variant does not contribute in the assessment of the risk for colorectal cancer in Ashkenazi Jews. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[7]  E. Jaramillo,et al.  Prevalence and incidence of hyperplastic polyps and adenomas in familial colorectal cancer: correlation between the two types of colon polyps , 2003, Gut.

[8]  J. Klijn,et al.  The CHEK2 1100delC mutation identifies families with a hereditary breast and colorectal cancer phenotype. , 2003, American journal of human genetics.

[9]  A. Lindblom,et al.  The role of hMLH3 in familial colorectal cancer. , 2003, Cancer research.

[10]  L. Lipton,et al.  Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH. , 2003, The New England journal of medicine.

[11]  R. Millikan,et al.  Family history of colon cancer: what does it mean and how is it useful? , 2003, American journal of preventive medicine.

[12]  J. Nadeau,et al.  Finding Genes That Underlie Complex Traits , 2002, Science.

[13]  E. D. de Vries,et al.  Low-penetrance genes and their involvement in colorectal cancer susceptibility. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[14]  S. Gabriel,et al.  The Structure of Haplotype Blocks in the Human Genome , 2002, Science.

[15]  R. Myers,et al.  Candidate-gene approaches for studying complex genetic traits: practical considerations , 2002, Nature Reviews Genetics.

[16]  J. Wardle,et al.  Single flexible sigmoidoscopy screening to prevent colorectal cancer: baseline findings of a UK multicentre randomised trial , 2002, The Lancet.

[17]  J. Beilby,et al.  A polymorphism in the methylenetetrahydrofolate reductase gene predisposes to colorectal cancers with microsatellite instability , 2002, Gut.

[18]  J. Hirschhorn,et al.  A comprehensive review of genetic association studies , 2002, Genetics in Medicine.

[19]  E. Jaramillo,et al.  Adenoma prevalence and cancer risk in familial non-polyposis colorectal cancer , 2002, Gut.

[20]  Alison L. Livingston,et al.  Inherited variants of MYH associated with somatic G:C→T:A mutations in colorectal tumors , 2002, Nature Genetics.

[21]  John A. Todd,et al.  Parameters for reliable results in genetic association studies in common disease , 2002, Nature Genetics.

[22]  S. P. Fodor,et al.  Blocks of Limited Haplotype Diversity Revealed by High-Resolution Scanning of Human Chromosome 21 , 2001, Science.

[23]  J. Ioannidis,et al.  Replication validity of genetic association studies , 2001, Nature Genetics.

[24]  W. Zoller,et al.  [Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer]. , 2001, Zeitschrift fur Gastroenterologie.

[25]  K. Kinzler,et al.  The role of hPMS1 and hPMS2 in predisposing to colorectal cancer. , 2001, Cancer research.

[26]  David Clayton,et al.  Epidemiological methods for studying genes and environmental factors in complex diseases , 2001, The Lancet.

[27]  M. Daly,et al.  High-resolution haplotype structure in the human genome , 2001, Nature Genetics.

[28]  R. Houlston,et al.  A systematic review and meta-analysis of familial colorectal cancer risk , 2001, American Journal of Gastroenterology.

[29]  Frank Dudbridge,et al.  Haplotype tagging for the identification of common disease genes , 2001, Nature Genetics.

[30]  H. Grönberg,et al.  Screening families with endometrial and colorectal cancers for germline mutations , 2001, Journal of medical genetics.

[31]  R. Houlston,et al.  Polymorphisms and colorectal tumor risk. , 2001, Gastroenterology.

[32]  R. Kolodner,et al.  exo1-Dependent Mutator Mutations: Model System for Studying Functional Interactions in Mismatch Repair , 2001, Molecular and Cellular Biology.

[33]  D. Goldstein,et al.  Population genomics: Linkage disequilibrium holds the key , 2001, Current Biology.

[34]  Pardis C Sabeti,et al.  Linkage disequilibrium in the human genome , 2001, Nature.

[35]  J. Herman,et al.  Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer. , 2001, Human molecular genetics.

[36]  D. Chasman,et al.  Predicting the functional consequences of non-synonymous single nucleotide polymorphisms: structure-based assessment of amino acid variation. , 2001, Journal of molecular biology.

[37]  P. Vineis,et al.  Misconceptions about the use of genetic tests in populations , 2001, The Lancet.

[38]  M. Daly,et al.  A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms , 2001, Nature.

[39]  H. Grönberg,et al.  MSH6 and MSH3 are rarely involved in genetic predisposition to nonpolypotic colon cancer. , 2001, Cancer research.

[40]  J. Kaprio,et al.  Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland. , 2000, The New England journal of medicine.

[41]  John A. Todd,et al.  The genetically isolated populations of Finland and Sardinia may not be a panacea for linkage disequilibrium mapping of common disease genes , 2000, Nature Genetics.

[42]  N. Risch Searching for genetic determinants in the new millennium , 2000, Nature.

[43]  T. Liu,et al.  Microsatellite instability as a predictor of a mutation in a DNA mismatch repair gene in familial colorectal cancer , 2000, Genes, chromosomes & cancer.

[44]  R. Hultcrantz,et al.  Epidemiology of familial adenomatous polyposis in Sweden: changes over time and differences in phenotype between males and females. , 1999, Scandinavian journal of gastroenterology.

[45]  M. Cargill Characterization of single-nucleotide polymorphisms in coding regions of human genes , 1999, Nature Genetics.

[46]  W. Willett,et al.  A polymorphism of the methionine synthase gene: association with plasma folate, vitamin B12, homocyst(e)ine, and colorectal cancer risk. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[47]  A. Long,et al.  The power of association studies to detect the contribution of candidate genetic loci to variation in complex traits. , 1999, Genome research.

[48]  L. Kruglyak Prospects for whole-genome linkage disequilibrium mapping of common disease genes , 1999, Nature Genetics.

[49]  L. Aaltonen,et al.  Cancer risk in mutation carriers of DNA‐mismatch‐repair genes , 1999, International journal of cancer.

[50]  K. Kinzler,et al.  Analysis of masked mutations in familial adenomatous polyposis. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[51]  P. Peltomäki,et al.  Genetic polymorphisms in carcinogen metabolism and their association to hereditary nonpolyposis colon cancer. , 1998, Gastroenterology.

[52]  N Risch,et al.  The relative power of family-based and case-control designs for linkage disequilibrium studies of complex human diseases I. DNA pooling. , 1998, Genome research.

[53]  H. Grönberg,et al.  MSH2 codon 322 Gly to Asp seems not to confer an increased risk for colorectal cancer susceptibility. , 1998, European journal of cancer.

[54]  M. Koike,et al.  Germline mutation of MSH6 as the cause of hereditary nonpolyposis colorectal cancer , 1997, Nature Genetics.

[55]  H. Ostrer,et al.  Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC , 1997, Nature Genetics.

[56]  J. Olsen,et al.  Randomised study of screening for colorectal cancer with faecal-occult-blood test , 1996, The Lancet.

[57]  B. Carstensen,et al.  Familial aggregation of colorectal cancer in the general population , 1996, International journal of cancer.

[58]  E. Rimm,et al.  A methylenetetrahydrofolate reductase polymorphism and the risk of colorectal cancer. , 1996, Cancer research.

[59]  N Risch,et al.  The Future of Genetic Studies of Complex Human Diseases , 1996, Science.

[60]  E. Lander,et al.  Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results , 1995, Nature Genetics.

[61]  K. Kinzler,et al.  Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. , 1995, Science.

[62]  G A Colditz,et al.  A prospective study of family history and the risk of colorectal cancer. , 1994, The New England journal of medicine.

[63]  R. Fleischmann,et al.  Mutation of a mutL homolog in hereditary colon cancer. , 1994, Science.

[64]  D. Ward,et al.  Mutation in the DNA mismatch repair gene homologue hMLH 1 is associated with hereditary non-polyposis colon cancer , 1994, Nature.

[65]  Robin J. Leach,et al.  Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer , 1993, Cell.

[66]  N. Copeland,et al.  The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer , 1993, Cell.

[67]  A. Lindblom,et al.  Genetic mapping of a second locus predisposing to hereditary non–polyposis colon cancer , 1993, Nature Genetics.

[68]  Tomas A. Prolla,et al.  Destabilization of tracts of simple repetitive DNA in yeast by mutations affecting DNA mismatch repair , 1993, Nature.

[69]  D. S. St. John,et al.  Cancer Risk in Relatives of Patients with Common Colorectal Cancer , 1993, Annals of Internal Medicine.

[70]  K. Kinzler,et al.  Clues to the pathogenesis of familial colorectal cancer. , 1993, Science.

[71]  J. Weber,et al.  Genetic mapping of a locus predisposing to human colorectal cancer. , 1993, Science.

[72]  Bert Vogelstein,et al.  APC mutations occur early during colorectal tumorigenesis , 1992, Nature.

[73]  J. Mecklin,et al.  Tumor spectrum in cancer family syndrome (hereditary nonpolyposis colorectal cancer) , 1991, Cancer.

[74]  S. Altschul,et al.  Identification of FAP locus genes from chromosome 5q21. , 1991, Science.

[75]  Margaret Robertson,et al.  Identification and characterization of the familial adenomatous polyposis coli gene , 1991, Cell.

[76]  J. Mecklin,et al.  The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC) , 1991, Diseases of the colon and rectum.

[77]  B. Vogelstein,et al.  A genetic model for colorectal tumorigenesis , 1990, Cell.

[78]  S. Moss,et al.  Randomised controlled trial of faecal-occult-blood screening for colorectal cancer , 1989, The Lancet.

[79]  F. C. Lucibello,et al.  Localization of the gene for familial adenomatous polyposis on chromosome 5 , 1987, Nature.

[80]  A. Sandberg,et al.  Gardner syndrome in a man with an interstitial deletion of 5q. , 1986, American journal of medical genetics.

[81]  Eileen Lovett,et al.  Family studies in cancer of the colon and rectum , 1976, The British journal of surgery.

[82]  H. Lynch,et al.  Cancer family “G” revisited: 1895‐1970 , 1971, Cancer.

[83]  A. Lindblom,et al.  Family history of colorectal cancer in a Sweden county , 2004, Familial Cancer.

[84]  S. Bülow,et al.  Attenuated familial adenomatous polyposis (AFAP): a review of the literature , 2004, Familial Cancer.

[85]  A. Lindblom,et al.  Missense mutations in hMLH1 associated with colorectal cancer , 1999, Human Genetics.